Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,371 | -9,049 | -37,244 | -27,064 | -17,831 |
| Depreciation Amortization | 191 | 72 | 431 | 273 | 166 |
| Other Working Capital | -1,158 | -2,216 | 6,007 | 3,300 | 969 |
| Other Operating Activity | 2,941 | 1,330 | 5,217 | 4,483 | 2,731 |
| Operating Cash Flow | $-16,396 | $-9,862 | $-25,589 | $-19,008 | $-13,965 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,124 | -2,829 | -105,566 | -49,173 | -61,570 |
| PPE Investments | -7 | -3 | -20 | N/A | N/A |
| Sale Of Investment | 29,816 | 3,912 | 54,663 | N/A | N/A |
| Investing Cash Flow | $15,685 | $1,080 | $-50,923 | $-49,173 | $-61,570 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 105 | 28 | 64,881 | 64,461 | 64,461 |
| Financing Cash Flow | $105 | $28 | $64,881 | $64,461 | $64,461 |
| Beginning Cash Position | 13,376 | 13,376 | 25,007 | 25,007 | 25,007 |
| End Cash Position | 12,769 | 4,623 | 13,376 | 21,287 | 13,933 |
| Net Cash Flow | $-607 | $-8,753 | $-11,631 | $-3,721 | $-11,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,396 | -9,862 | -25,589 | -19,008 | -13,965 |
| Capital Expenditure | -7 | -3 | -20 | N/A | N/A |
| Free Cash Flow | -16,403 | -9,864 | -25,609 | -19,008 | -13,965 |